Active ingredientNilotinibCat. No. P-N063-001CAS 641571-10-0Family · Pharmaceutical analytical standards
Nilotinib
A second-generation BCR-ABL tyrosine kinase inhibitor, approved in 2007 for Philadelphia chromosome-positive chronic myeloid leukaemia, first in imatinib-resistant cases and later also at diagnosis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It was designed starting from the crystal structure of imatinib bound to its target: the targeted changes make it 10 to 30 times more potent at blocking BCR-ABL.
Go to the active ingredient →Active ingredientNilotinibCat. No. P-N063-001CAS 641571-10-0
Active ingredientNilotinib Hydrochloride MonohydrateCat. No. P-N063-002CAS 923288-90-8
Pharmacopoeial impurityNilotinib EP Impurity ACat. No. P-N063-003CAS 641571-11-1
Pharmacopoeial impurityNilotinib EP Impurity BCat. No. P-N063-004CAS 18595-18-1
Pharmacopoeial impurityNilotinib EP Impurity CCat. No. P-N063-005CAS 2458-12-0
Pharmacopoeial impurityNilotinib EP Impurity DCat. No. P-N063-006CAS 641569-94-0
Pharmacopoeial impurityNilotinib EP Impurity ECat. No. P-N063-007CAS 2119583-26-3
Pharmacopoeial impurityNilotinib EP Impurity FCat. No. P-N063-008CAS 2119583-24-1
Pharmacopoeial impurityNilotinib EP Impurity GCat. No. P-N063-009CAS 917392-54-2
Pharmacopoeial impurityNilotinib EP Impurity HCat. No. P-N063-010CAS 641571-15-5
Isotopically labelledNilotinib-d6Cat. No. P-N063-011CAS 1268356-17-7
NitrosamineN-Nitroso NilotinibCat. No. P-N063-012CAS 2925306-68-7
ImpurityNilotinib Impurity 1Cat. No. P-N063-013CAS 641571-14-4
ImpurityNilotinib Impurity 2Cat. No. P-N063-014CAS 63156-74-1
ImpurityNilotinib Impurity 3Cat. No. P-N063-015CAS 943320-48-7
ImpurityNilotinib Impurity 4Cat. No. P-N063-016CAS 641571-06-4
ImpurityNilotinib Impurity 5Cat. No. P-N063-017CAS 641571-13-3
ImpurityNilotinib Impurity 6Cat. No. P-N063-018CAS 641571-12-2
ImpurityNilotinib Impurity 7Cat. No. P-N063-019CAS 917391-28-7
ImpurityNilotinib Impurity 8Cat. No. P-N063-020CAS 641571-16-6
ImpurityNilotinib Impurity 9Cat. No. P-N063-021CAS 915711-42-1
ImpurityNilotinib Impurity 10Cat. No. P-N063-023CAS 916975-92-3
ImpurityNilotinib Impurity 11Cat. No. P-N063-024CAS 851137-91-2
ImpurityNilotinib Impurity 12Cat. No. P-N063-025CAS 1157857-29-8
ImpurityNilotinib Impurity 13 NitrateCat. No. P-N063-026CAS 641569-96-2
ImpurityEthyl 3-Amino-4-methylbenzoateCat. No. P-N063-027CAS 41191-92-8
ImpurityNilotinib Impurity 14Cat. No. P-N063-028CAS 641569-97-3
ImpurityNilotinib Impurity 15Cat. No. P-N063-029CAS 2021249-11-4
ImpurityNilotinib 3-Guanidino ImpurityCat. No. P-N063-030CAS 1345336-53-9
ImpurityNilotinib 3-Pyridinyl ImpurityCat. No. P-N063-031CAS 66521-66-2
ImpurityNilotinib Bromo ImpurityCat. No. P-N063-032CAS 54962-75-3
ImpurityNilotinib Impurity 16 HydrochlorideCat. No. P-N063-034
ImpurityNilotinib Impurity 17Cat. No. P-N063-035
ImpurityNilotinib Impurity 18Cat. No. P-N063-036CAS 2469039-94-7
ImpurityNilotinib Impurity 19Cat. No. P-N063-037CAS 1807606-80-9
ImpurityNilotinib Impurity 20Cat. No. P-N063-038CAS 1807607-72-2
ImpurityNilotinib Impurity 21Cat. No. P-N063-039
ImpurityNilotinib Impurity 22Cat. No. P-N063-040CAS 641571-05-3
ImpurityNilotinib Impurity 23Cat. No. P-N063-041
ImpurityNilotinib Impurity D HClCat. No. P-N063-042
ImpurityNilotinib Impurity E HClCat. No. P-N063-043
ImpurityNilotinib Iodo ImpurityCat. No. P-N063-044CAS 926922-18-1
ImpurityNilotinib Impurity 24Cat. No. P-N063-045
ImpurityNilotinib Impurity 25Cat. No. P-N063-046CAS 1246817-85-5
ImpurityNilotinib Impurity 26Cat. No. P-N063-047CAS 2139382-75-3No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Reference substanceNilotinib hydrochloride monohydrate CRSEDQM code Y0002097Family NilotinibImpurityNilotinib impurity A CRSEDQM code Y0002103Family NilotinibImpurityNilotinib impurity B CRSEDQM code Y0002111Family NilotinibImpurityNilotinib impurity C CRSEDQM code Y0002108Family NilotinibNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.